IndAS Details

Scrip Code	532300
NSE Symbol	WOCKPHARMA
MSEI Symbol	NA
ISIN	INE049B01025
Name of company	Wockhardt Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-04-2025
Date of end of financial year	31-03-2026
Date of board meeting when results were approved	04-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	28-04-2026
Description of presentation currency	INR
Level of rounding used in financial results	Lakhs
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Pharmaceuticals
Start date and time of board meeting	04-05-2026 11:00:00
End date and time of board meeting	04-05-2026 15:10:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	03-11-2025
Indicate Company website link for updated RPT policy of the Company	https://www.wockhardt.com/wp-content/uploads/2026/02/policy-on-rpt.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	Yes
No. of times funds raised during the quarter	1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Not Applicable as there is no default on loans and the company has no outstanding debt securities as on 31.03.2026.

Particulars	3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2026	01-04-2025
B	Date of end of reporting period	31-03-2026	31-03-2026
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
1	Income
	Revenue from operations	51,600.00	1,73,900.00
	Other income	5,500.00	13,700.00
	Total income	57,100.00	1,87,600.00
2	Expenses
(a)	Cost of materials consumed	7,900.00	30,900.00
(b)	Purchases of stock-in-trade	4,000.00	19,800.00
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	100.00	(9,200.00)
(d)	Employee benefit expense	7,900.00	31,300.00
(e)	Finance costs	4,100.00	17,600.00
(f)	Depreciation, depletion and amortisation expense	4,300.00	18,600.00
(f)	Other Expenses
1	Other expenses	15,600.00	49,400.00
	Total other expenses	15,600.00	49,400.00
	Total expenses	43,900.00	1,58,400.00
3	Total profit before exceptional items and tax	13,200.00	29,200.00
4	Exceptional items	3,500.00	2,500.00
5	Total profit before tax	16,700.00	31,700.00
6	Tax expense
7	Current tax	0.00	0.00
8	Deferred tax	0.00	0.00
9	Total tax expenses	0.00	0.00
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0.00	0.00
11	Net Profit Loss for the period from continuing operations	16,700.00	31,700.00
12	Profit (loss) from discontinued operations before tax	0.00	0.00
13	Tax expense of discontinued operations	0.00	0.00
14	Net profit (loss) from discontinued operation after tax	0.00	0.00
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0.00	0.00
16	Total profit (loss) for period	16,700.00	31,700.00
17	Other comprehensive income net of taxes	100.00	0.00
18	Total Comprehensive Income for the period	16,800.00	31,700.00
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	8,100.00	8,100.00
	Face value of equity share capital	5	5
27	Details of debt securities
22	Reserves excluding revaluation reserve		3,00,300.00
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	10.29	19.54
	Diluted earnings (loss) per share from continuing operations	10.28	19.52
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	10.29	19.54
	Diluted earnings (loss) per share from continuing and discontinued operations	10.28	19.52
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results	Textual Information(1)

Textual Information(1)	1. The results were reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on May 4, 2026. The Statutory Auditors have expressed an unmodified audit opinion with respect to the Audited Financial Results of the Company for the year ended March 31, 2026. 2. Figures for the quarter ended March 31, 2026 and March 31, 2025 are the balancing figures between the audited figures of the full financial year and the reviewed figures upto the four quarter of the relevant financial year. 3. The Company is exclusively into Pharmaceutical business segment. 4.Further to the approval of the Board of Directors and Shareholders at their meetings, the Company has, on November 11, 2024, alloted 9,049,773 Equity Shares of Rs. 5/- each to Qualified Institutional Buyers at the issue price of Rs.1,105/- per share, aggregating to approximately Rs. 1,000 crore. 6.a) Settlement of Legal Dispute (Dr. Reddy’s Laboratories) : The Company had previously concluded a Business Transfer Agreement (“BTA”) with Dr. Reddy’s Laboratories Limited (“Purchaser”) on February 12, 2020, with further amendments thereto, for the transfer of a portion of its Domestic Branded Division. Out of the total consideration of Rs. 1,850 Crores, an amount of Rs. 300 Crores was designated as a “Holdback Amount” to be released contingent upon the Business Undertaking achieving specific revenue benchmarks. The Company entered into a settlement agreement with Purchaser towards full and final settlement of all claims and disputes under BTA and legal proceedings effective March 31, 2026 and recognized net gain of Rs. 35 crore under 'Exceptional Items' for the quarter ended March 31, 2026. b) Impact of New Labour Codes: Effective November 21, 2025, the Government of India has consolidated multiple existing labour legislations into a unified framework comprising four Labour Codes ('Code'). All set of rules under the Code are yet to be notified. The Company has assessed and accounted the incremental impact of the new Code based on the best available information and actuarial valuation amounting to Rs. 10 Crores as 'Exceptional items'. The Company continues to monitor the finalisation of Central / State Rules and clarifications from the Government on other aspects of the Labour Code and would provide appropriate accounting effect on the basis of such developments as needed. Please also, additionally refer to the Statement of Standalone Audited Results for the quarter and year ended March 31, 2026 as attached to the Outcome of Board Meeting.

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Particulars	Year ended (dd-mm-yyyy)
Date of start of reporting period	01-04-2025
Date of end of reporting period	31-03-2026
Whether results are audited or unaudited	Audited
Nature of report standalone or consolidated	Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	1,12,800.00
	Capital work-in-progress	12,100.00
	Investment property	0.00
	Goodwill	0.00
	Other intangible assets	22,400.00
	Intangible assets under development	1,27,600.00
	Biological assets other than bearer plants	0.00
	Investments accounted for using equity method	0.00
	Non-current financial assets
	Non-current investments	29,745.00
	Trade receivables, non-current	0.00
	Loans, non-current	0.00
	Other non-current financial assets
1	Rounding Difference	(45.00)
2	Other non-current financial assets	7,300.00
	Total of other non-current financial assets	7,255.00
	Total non-current financial assets	37,000.00
	Deferred tax assets (net)	25,000.00
	Other non-current assets
1	Non-current tax assets (Net)	7,800.00
2	Other non-current assets	10,700.00
	Total of other non-current assets	18,500.00
	Total non-current assets	3,55,400.00
2	Current assets
	Inventories	53,300.00
	Current financial asset
	Current investments	41,200.00
	Trade receivables, current	84,600.00
	Cash and cash equivalents	7,600.00
	Bank balance other than cash and cash equivalents	3,100.00
	Loans, current	0.00
	Other current financial assets
	Total of other current financial assets	10,300.00
	Total current financial assets	1,46,800.00
	Current tax assets (net)	28,900.00
	Other current assets
	Total of other current assets
	Total current assets	2,29,000.00
3	Non-current assets classified as held for sale	9,100.00
4	Regulatory deferral account debit balances and related deferred tax Assets	0.00
	Total assets	5,93,500.00
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	8,100.00
	Other equity	3,00,300.00
	Total equity attributable to owners of parent	3,08,400.00
	Non controlling interest
	Total equity	3,08,400.00
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	1,24,400.00
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0.00
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0.00
	Total Trade payable	0.00
	Other non-current financial liabilities
1	Lease Liabilities	14,100.00
	Total of other non-current financial liabilities	14,100.00
	Total non-current financial liabilities	1,38,500.00
	Provisions, non-current	4,000.00
	Deferred tax liabilities (net)	0.00
	Deferred government grants, Non-current	0.00
	Other non-current liabilities
	Total of other non-current liabilities
	Total non-current liabilities	1,42,500.00
	Current liabilities
	Current financial liabilities
	Borrowings, current	50,100.00
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	8,500.00
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	41,800.00
	Total Trade payable	50,300.00
	Other current financial liabilities
1	Lease Liabilities	7,800.00
2	Other current financial liabilities	18,900.00
	Total of other current financial liabilities	26,700.00
	Total current financial liabilities	1,27,100.00
	Other current liabilities	12,000.00
1	Other current liabilities	12,000.00
	Total of other current liabilities	12,000.00
	Provisions, current	3,300.00
	Current tax liabilities (Net)	200.00
	Deferred government grants, Current	0.00
	Total current liabilities	1,42,600.00
3	Liabilities directly associated with assets in disposal group classified as held for sale	0.00
4	Regulatory deferral account credit balances and related deferred tax liability	0.00
	Total liabilities	2,85,100.00
	Total equity and liabilites	5,93,500.00
	Disclosure of notes on assets and liabilities	Textual Information(1)

Textual Information(1)	March 31, 2026 as attached to the Outcome of Board Meeting. Notes to Assets Liabilities 1. Property, Plant and Equipment of Rs.907 crore includes Right of use assets amounting to Rs.221 crore. 2.Non current investments consists of Investment in subsidiaries Rs.297 Crore and other investment Rs.0.45 Crore Notes to Cash Flow Statements: 1. Cash inflow (outflow) of cash consists of Margin money under lien and Bank balances (other than cash and cash equivalents) Rs. 29 Crore, Guarantee Commission received Rs. 3 crore 3.Proceeds from borrowings consists of Proceeds from long term borrowing amounting to Rs. 600 Crore and loan from Related Parties- Long term of Rs. 137 Crore. 3.Repayment of Borrowings consists of repayment of long term borrowing amounting to Rs.99 crore, Repayment of loan taken from related parties-long term amounting Rs 325crore,Repayment of loans taken from related parties- short term amounting Rs.42 crore and short term borrowing( net ) Rs 50 crore. 4.Other adjustments for non cash items includes Allowance for expected credit loss, doubtful advances and bad debts Rs. 17 crore, profit on sale of fixed assets (net) Rs. (55) Crore, Gain on sale of investment Rs. (17) crore 5.Aggregated/ segregated in accordance with the prescribed format and to the extent is the requirement of the accounting standard. 6.Other inflow (outflow) of cash – consists of finance cost paid Rs. 149 crore 6.Proceeds from sales of investments property consists sale of current investments (net) 7. Proceeds from issuing other equity instruments consists of – proceeds from issuance of equity share capital under ESOS Rs. 0.003 crore. 8. The above statement of cash flows has been prepared under the indirect method as set out in Ind AS 7 'Statement of Cash Flows'. 9. Repayment of lease liabilities consists of: Payment of interest Rs. 23 crore (Previous period - Rs. 27 crore) Payment of Principal Rs. 56 crore (Previous period - Rs. 48 crore)

Particulars	3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period	01-01-2026	01-04-2025
Date of end of reporting period	31-03-2026	31-03-2026
Whether results are audited or unaudited	Audited	Audited
Nature of report standalone or consolidated	Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Particulars	3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2026	01-04-2025
B	Date of end of reporting period	31-03-2026	31-03-2026
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Items that will not be reclassified to Profit or Loss - charge (consisting of re-measurement of net defined benefit liability)	100.00	8.00
2	Income tax relating to items that will not be reclassified to Profit or Loss	0.00	0.00
3	Other Comprehensive Income (net of tax)	0.00	0.00
4	Rounding off	0.00	(8.00)
	Total Amount of items that will not be reclassified to profit and loss	100.00	0.00
2	Income tax relating to items that will not be reclassified to profit or loss	0.00	0.00
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0.00	0.00
5	Total Other comprehensive income	100.00	0.00

Particulars	Year ended (dd-mm-yyyy)
A	Date of start of reporting period	01-04-2025
B	Date of end of reporting period	31-03-2026
C	Whether results are audited or unaudited	Audited
D	Nature of report standalone or consolidated	Standalone
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax	31,700.00
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs	17,600.00
	Adjustments for decrease (increase) in inventories	(10,700.00)
	Adjustments for decrease (increase) in trade receivables, current	(20,200.00)
	Adjustments for decrease (increase) in trade receivables, non-current	0.00
	Adjustments for decrease (increase) in other current assets	2,600.00
	Adjustments for decrease (increase) in other non-current assets	0.00
	Adjustments for other financial assets, non-current	0.00
	Adjustments for other financial assets, current	0.00
	Adjustments for other bank balances	0.00
	Adjustments for increase (decrease) in trade payables, current	800.00
	Adjustments for increase (decrease) in trade payables, non-current	0.00
	Adjustments for increase (decrease) in other current liabilities	(5,700.00)
	Adjustments for increase (decrease) in other non-current liabilities	0.00
	Adjustments for depreciation and amortisation expense	18,600.00
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss	0.00
	Adjustments for provisions, current	0.00
	Adjustments for provisions, non-current	0.00
	Adjustments for other financial liabilities, current	0.00
	Adjustments for other financial liabilities, non-current	0.00
	Adjustments for unrealised foreign exchange losses gains	(3,200.00)
	Adjustments for dividend income	0.00
	Adjustments for interest income	700.00
	Adjustments for share-based payments	400.00
	Adjustments for fair value losses (gains)	(1,300.00)
	Adjustments for undistributed profits of associates	0.00
	Other adjustments for which cash effects are investing or financing cash flow	0.00
	Other adjustments to reconcile profit (loss)	0.00
	Other adjustments for non-cash items	(5,500.00)
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships	0.00
	Total adjustments for reconcile profit (loss)	(7,300.00)
	Net cash flows from (used in) operations	24,400.00
	Dividends received	0.00
	Interest paid	0.00
	Interest received	0.00
	Income taxes paid (refund)	300.00
	Other inflows (outflows) of cash	0.00
	Net cash flows from (used in) operating activities	24,100.00
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses	0.00
	Cash flows used in obtaining control of subsidiaries or other businesses	0.00
	Other cash receipts from sales of equity or debt instruments of other entities	0.00
	Other cash payments to acquire equity or debt instruments of other entities	0.00
	Other cash receipts from sales of interests in joint ventures	0.00
	Other cash payments to acquire interests in joint ventures	0.00
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships	0.00
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships	0.00
	Proceeds from sales of property, plant and equipment	5,300.00
	Purchase of property, plant and equipment	8,600.00
	Proceeds from sales of investment property	3,900.00
	Purchase of investment property	0.00
	Proceeds from sales of intangible assets	0.00
	Purchase of intangible assets	0.00
	Proceeds from sales of intangible assets under development	0.00
	Purchase of intangible assets under development	23,400.00
	Proceeds from sales of goodwill	0.00
	Purchase of goodwill	0.00
	Proceeds from biological assets other than bearer plants	0.00
	Purchase of biological assets other than bearer plants	0.00
	Proceeds from government grants	0.00
	Proceeds from sales of other long-term assets	0.00
	Purchase of other long-term assets	0.00
	Cash advances and loans made to other parties	0.00
	Cash receipts from repayment of advances and loans made to other parties	0.00
	Cash payments for future contracts, forward contracts, option contracts and swap contracts	0.00
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts	0.00
	Dividends received	0.00
	Interest received	300.00
	Income taxes paid (refund)	0.00
	Other inflows (outflows) of cash	3,200.00
	Net cash flows from (used in) investing activities	(19,300.00)
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries	0.00
	Payments from changes in ownership interests in subsidiaries	0.00
	Proceeds from issuing shares	0.00
	Proceeds from issuing other equity instruments	0.00
	Payments to acquire or redeem entity's shares	0.00
	Payments of other equity instruments	0.00
	Proceeds from exercise of stock options	0.00
	Proceeds from issuing debentures notes bonds etc	0.00
	Proceeds from borrowings	73,700.00
	Repayments of borrowings	51,600.00
	Payments of lease liabilities	7,900.00
	Dividends paid	0.00
	Interest paid	0.00
	Income taxes paid (refund)	0.00
	Other inflows (outflows) of cash	(14,900.00)
	Net cash flows from (used in) financing activities	(700.00)
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes	4,100.00
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents	0.00
	Net increase (decrease) in cash and cash equivalents	4,100.00
	Cash and cash equivalents cash flow statement at beginning of period	3,500.00
	Cash and cash equivalents cash flow statement at end of period	7,600.00

Whether results are audited or unaudited	Audited
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results	Yes

Sr No.	Audit firm's name	Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI	Certificate valid upto
1	M S K C & Associates LLP	Yes	30-09-2026

Mode of Fund Raising	QIP
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds	11-11-2024
Amount Raised	1,00,000.00
Report filed for Quarter ended	31-03-2026
Monitoring Agency	Applicable
Monitoring Agency Name, if applicable	CRISIL RATINGS LIMITED
Is there a Deviation / Variation in use of funds raised	No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation	NA
Comments of the Audit Committee after review	NIL
Comments of the auditors, if any	NIL

	Name	Name	Relationship of the counterparty with the listed entity or its subsidiary	Type of related party transaction	Details of other related party transaction		Remarks on approval by audit committee			Value of transaction during the reporting period	Opening balance	Closing balance	Nature of indebtedness (loan/ issuance of debt/ any other etc.)	Details of other indebtedness	Nature (loan/ advance/ intercorporate deposit/ investment )	Notes
Sr No.														Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
	Details of the party (listed entity/subsidiary) entering into the transaction	Details of the counterparty		Type of related party transaction	Details of other related party transaction	Value of the related party transaction as approved by the audit committee	Remarks on approval by audit committee	Value of the related party transaction ratified by the audit committee	Date of Audit Committee Meeting where the ratification was approved	Value of transaction during the reporting period	In case monies are due to either party as a result of the transaction		In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments		Details of the loans, inter-corporate deposits, advances or investments	Notes
1	Wockhardt Limited	Wockhardt Bio Ag	Subsidiary	Any other transaction	Purchase of Intellectual Property	4,43,926.00	Approved			12,872.00	0.00	0.00				Textual Information(1)
2	Wockhardt Limited	CP Pharmaceuticals Limited	Step down subsidiary	Purchase of goods or services		4,43,926.00	Approved			136.00	0.00	0.00
3	Wockhardt Limited	Wockhardt Bio Ag	Subsidiary	Sale of goods or services		4,43,926.00	Approved			5,907.00	0.00	0.00
4	Wockhardt Limited	CP Pharmaceuticals Limited	Step down subsidiary	Advance		4,43,926.00	Approved			240.00	0.00	0.00
5	Wockhardt Limited	CP Pharmaceuticals Limited	Step down subsidiary	Any other transaction	Advance Adjusted against Purchases	4,43,926.00	Approved			240.00	0.00	0.00
6	Wockhardt Limited	CP Pharmaceuticals Limited	Step down subsidiary	Sale of goods or services		4,43,926.00	Approved			10.00	0.00	0.00
7	Wockhardt Limited	Wockhardt UK Limited	Step down subsidiary	Sale of goods or services		4,43,926.00	Approved			23.00	0.00	0.00
8	Wockhardt Limited	Wockhardt Bio Ag	Subsidiary	Sale of goods or services		4,43,926.00	Approved			217.00	0.00	0.00
9	Wockhardt Limited	Pinewood Laboratories Ltd	Step down subsidiary	Sale of goods or services		4,43,926.00	Approved			26.00	0.00	0.00
10	Wockhardt Limited	Wockhardt Bio Ag	Subsidiary	Sale of goods or services		4,43,926.00	Approved			7,872.00	0.00	0.00
11	Wockhardt Limited	CP Pharmaceuticals Limited	Step down subsidiary	Sale of goods or services		4,43,926.00	Approved			17.00	0.00	0.00
12	Wockhardt Limited	Wockhardt Bio (R) LLC	Step down subsidiary	Sale of goods or services		27,900.00	Approved			2,316.00	0.00	0.00
13	Wockhardt Limited	Wockhardt Infrastructure Development Limited	Wholly Owned Subsidiary	Purchase of goods or services		0.00	Not Applicable			841.00	0.00	0.00
14	Wockhardt Limited	Wockhardt Infrastructure Development Limited	Wholly Owned Subsidiary	Purchase of goods or services		0.00	Not Applicable			761.00	0.00	0.00
15	Wockhardt Limited	Wockhardt Infrastructure Development Limited	Wholly Owned Subsidiary	Purchase of goods or services		0.00	Not Applicable			1.00	0.00	0.00
16	Wockhardt Limited	Wockhardt Infrastructure Development Limited	Wholly Owned Subsidiary	Any other transaction	Recovery of Support Service cost	0.00	Not Applicable			6.00	0.00	0.00
17	Wockhardt Limited	Wockhardt Bio Ag	Subsidiary	Any other transaction	Reimbursement received	0.00	Not Applicable			16.00	0.00	0.00
18	Wockhardt Limited	Wockhardt Bio (R) LLC	Step down subsidiary	Any other transaction	Reimbursement received	0.00	Not Applicable			19.00	0.00	0.00
19	Wockhardt Limited	Wockhardt Bio Ag	Subsidiary	Any other transaction	Reimbursement paid	0.00	Not Applicable			91.00	0.00	0.00
20	Wockhardt Limited	Wockhardt Bio (R) LLC	Step down subsidiary	Any other transaction	Reimbursement paid	0.00	Not Applicable			375.00	0.00	0.00
21	Wockhardt Limited	Wockhardt Bio (R) LLC	Step down subsidiary	Any other transaction	Advances Received against Export of Goods	5,000.00	Approved			1,120.00	0.00	0.00
22	Wockhardt Limited	Wockhardt Bio (R) LLC	Step down subsidiary	Any other transaction	Advances adjusted against Export of Goods and Services	5,000.00	Approved			248.00	0.00	0.00
23	Wockhardt Limited	Khorakiwala Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Loan Repaid	0.00	Not Applicable			11,526.00	0.00	0.00
24	Wockhardt Limited	Khorakiwala Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Interest Expenses	1,50,000.00	Approved			948.00	5,691.00	4,134.00
25	Wockhardt Limited	Khorakiwala Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Interest paid		1,50,000.00	Approved			2,286.00	0.00	0.00
26	Wockhardt Limited	Khorakiwala Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Lease Rent Income	20.00	Approved			6.00	0.00	0.00
27	Wockhardt Limited	Merind Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Interest Expense	26,000.00	Approved			465.00	3,127.00	3,344.00
28	Wockhardt Limited	Merind Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Recovery of Support Service Cost	20.00	Approved			6.00	0.00	0.00
29	Wockhardt Limited	Merind Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Interest paid		26,000.00	Approved			154.00	0.00	0.00
30	Wockhardt Limited	Themisto Trustee Company Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Loan Repaid	0.00	Not Applicable			1,946.00	0.00	0.00
31	Wockhardt Limited	Themisto Trustee Company Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Interest Expense	26,000.00	Approved			36.00	121.00	0.00
32	Wockhardt Limited	Ananke Trustee Company Pvt Ltd	Enterprises over which Key Managerial Personnel exercise significant influence/control	Loan		26,000.00	Approved			10,787.00	22,064.00	19,017.00
33	Wockhardt Limited	Ananke Trustee Company Pvt Ltd	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Loan Repaid	0.00	Not Applicable			13,834.00	0.00	0.00
34	Wockhardt Limited	Ananke Trustee Company Pvt Ltd	Enterprises over which Key Managerial Personnel exercise significant influence/control	Interest paid		26,000.00	Approved			512.00	0.00	0.00
35	Wockhardt Limited	Ananke Trustee Company Pvt Ltd	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Interest Expense	26,000.00	Approved			931.00	5,042.00	5,397.00
36	Wockhardt Limited	Callirhoe Trustee Company Pvt Ltd	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Loan Repaid	0.00	Not Applicable			4,413.00	0.00	0.00
37	Wockhardt Limited	Callirhoe Trustee Company Pvt Ltd	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Interest Expense	26,000.00	Approved			332.00	4,909.00	4,945.00
38	Wockhardt Limited	Callirhoe Trustee Company Pvt Ltd	Enterprises over which Key Managerial Personnel exercise significant influence/control	Interest paid		26,000.00	Approved			268.00	0.00	0.00
39	Wockhardt Limited	Palanpur Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Loan		26,000.00	Approved			1,713.00	15,778.00	15,778.00
40	Wockhardt Limited	Palanpur Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Loan Repaid	0.00	Not Applicable			1,713.00	0.00	0.00
41	Wockhardt Limited	Palanpur Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Interest paid		26,000.00	Approved			92.00	0.00	0.00
42	Wockhardt Limited	Palanpur Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Interest Expense	26,000.00	Approved			781.00	2,477.00	3,007.00
43	Wockhardt Limited	Carol Info Services Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Purchase of goods or services		27,900.00	Approved			4,610.00	0.00	0.00
44	Wockhardt Limited	Carol Info Services Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Sale of goods or services		27,900.00	Approved			20.00	0.00	0.00
45	Wockhardt Limited	Carol Info Services Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Reimbursement paid	0.00	Not Applicable			55.00	0.00	0.00
46	Wockhardt Limited	Holmdene Constructions	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Recovery of Cost	0.00	Not Applicable			1.00	0.00	0.00
47	Wockhardt Limited	Merind Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Sale of goods or services		28,000.00	Approved			1.00	0.00	0.00
48	Wockhardt Limited	Wockhardt Hospitals Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Sale of goods or services		27,900.00	Approved			1.00	0.00	0.00				Textual Information(2)
49	Wockhardt Limited	Wockhardt Regenerative Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Purchase of goods or services		27,900.00	Approved			571.00	0.00	0.00
50	Wockhardt Limited	Dr. Habil Khorakiwala Education and Health Foundation ( Trust) [Wockhardt Global School]	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Reimbursement received	0.00	Not Applicable			112.00	0.00	0.00
51	Wockhardt Limited	Dr. Habil Khorakiwala Education and Health Foundation ( Trust) [Wockhardt Global School]	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Recovery of Cost	0.00	Not Applicable			355.00	0.00	0.00
52	Wockhardt Limited	Dr. Habil Khorakiwala Education and Health Foundation ( Trust) [Wockhardt Global School]	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Reimbursement paid	0.00	Not Applicable			182.00	0.00	0.00				Textual Information(3)
53	Wockhardt Limited	The Peace Mission Pvt. Ltd.	Enterprises over which Key Managerial Personnel exercise significant influence/control	Purchase of goods or services		0.00	Not Applicable			16.00	0.00	0.00
54	Wockhardt Limited	Palanpur Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Purchase of goods or services		27,900.00	Approved			46.00	0.00	0.00
55	Wockhardt Limited	Palanpur Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Recovery of Support Service Cost	20.00	Approved			6.00	0.00	0.00
56	Wockhardt Limited	Wockhardt Foundation	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	CSR spend	0.00	Not Applicable			80.00	0.00	0.00
57	Wockhardt Limited	Wockhardt Regenerative Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Sale of goods or services		27,900.00	Approved			1.00	0.00	0.00				Textual Information(4)
58	Wockhardt Limited	Dr. Habil F. Khorakiwala	Executive Chairman	Remuneration		500.00	Approved			251.00	0.00	0.00
59	Wockhardt Limited	Dr. Huzaifa H. Khorakiwala	Executive Director	Remuneration		280.00	Approved			134.00	0.00	0.00
60	Wockhardt Limited	Dr. Murtaza H. Khorakiwala	Managing Director	Remuneration		280.00	Approved			143.00	0.00	0.00
61	Wockhardt Limited	Ms. Zahabiya Khorakiwala	Non-Executive Director	Any other transaction	Reimbursement	0.00	Not Applicable			3.00	0.00	0.00
62	Wockhardt Limited	CP Pharmaceuticals Limited	Step down subsidiary	Any other transaction	Receivables (Balances)	0.00	Not Applicable			0.00	282.00	321.00
63	Wockhardt Limited	Z&Z Services GmbH	Step down subsidiary	Any other transaction	Receivables (Balances)	0.00	Not Applicable			0.00	11.00	11.00
64	Wockhardt Limited	Wockhardt USA LLC	Step down subsidiary	Any other transaction	Receivables (Balances)	0.00	Not Applicable			0.00	399.00	422.00
65	Wockhardt Limited	Wockhardt Bio Pty Limited	Step down subsidiary	Any other transaction	Receivables (Balances)	0.00	Not Applicable			0.00	2.00	2.00
66	Wockhardt Limited	Wockhardt Bio AG	Subsidiary	Any other transaction	Receivables (Balances)	0.00	Not Applicable			0.00	52,648.00	58,784.00
67	Wockhardt Limited	Wockhardt UK Limited	Step down subsidiary	Any other transaction	Receivables (Balances)	0.00	Not Applicable			0.00	682.00	748.00
68	Wockhardt Limited	Pinewood Laboratories Limited	Step down subsidiary	Any other transaction	Receivables (Balances)	0.00	Not Applicable			0.00	1,001.00	287.00
69	Wockhardt Limited	Wockhardt Bio (R) LLC	Step down subsidiary	Any other transaction	Receivables (Balances)	0.00	Not Applicable			0.00	343.00	2,285.00
70	Wockhardt Limited	Morton Grove Pharmaceuticals	Step down subsidiary	Any other transaction	Receivables (Balances)	0.00	Not Applicable			0.00	325.00	344.00
71	Wockhardt Limited	Wockhardt Farmaceutica SA DE CV	Step down subsidiary	Any other transaction	Receivables (Balances)	0.00	Not Applicable			0.00	662.00	701.00
72	Wockhardt Limited	CP Pharmaceuticals Limited	Step down subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	1,731.00	1,750.00
73	Wockhardt Limited	Wockhardt USA LLC	Step down subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	1,027.00	1,088.00
74	Wockhardt Limited	Wockhardt Bio AG	Subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	4,930.00	5,157.00
75	Wockhardt Limited	Wockhardt UK Limited	Step down subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	675.00	702.00
76	Wockhardt Limited	Pinewood Laboratories Limited	Step down subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	673.00	695.00
77	Wockhardt Limited	Wockhardt Bio (R) LLC	Step down subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	1,164.00	1,531.00
78	Wockhardt Limited	Morton Grove Pharmaceuticals	Step down subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	352.00	373.00
79	Wockhardt Limited	Wockhardt Infrastructure Development Limited	Wholly Owned Subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	12,071.00	12,969.00
80	Wockhardt Limited	CP Pharmaceuticals Limited	Step down subsidiary	Any other transaction	Payables for Capital Goods (Balances)	0.00	Not Applicable			0.00	326.00	339.00
81	Wockhardt Limited	Pinewood Laboratories Limited	Step down subsidiary	Any other transaction	Payables for Capital Goods (Balances)	0.00	Not Applicable			0.00	106.00	110.00
82	Wockhardt Limited	Wockhardt Bio AG	Subsidiary	Any other transaction	Payables for Capital Goods (Balances)	0.00	Not Applicable			0.00	6,811.00	9,773.00
83	Wockhardt Limited	CP Pharmaceuticals Limited	Step down subsidiary	Any other transaction	Other Liability (Balances)	0.00	Not Applicable			0.00	319.00	357.00
84	Wockhardt Limited	Wockhardt Bio (R) LLC	Step down subsidiary	Any other transaction	Advances from Subsidiaries Against Supply (Balances)	0.00	Not Applicable			0.00	528.00	1,400.00
85	Wockhardt Limited	Wockhardt Bio AG	Subsidiary	Any other transaction	Advances from Subsidiaries Against Supply (Balances)	0.00	Not Applicable			0.00	1,674.00	1,674.00
86	Wockhardt Limited	Wockhardt Bio AG	Subsidiary	Any other transaction	Guarantee Fees Receivable (Balances)	0.00	Not Applicable			0.00	3,952.00	4,186.00
87	Wockhardt Limited	Wockhardt Infrastructure Development Limited	Wholly Owned Subsidiary	Any other transaction	Security Deposit Given (Balances)	0.00	Not Applicable			0.00	685.00	685.00
88	Wockhardt Limited	Morton Grove Pharmaceuticals	Step down subsidiary	Any other transaction	Other Receivables (Expense Recovery Balances)	0.00	Not Applicable			0.00	635.00	673.00
89	Wockhardt Limited	Wockhardt Infrastructure Development Limited	Wholly Owned Subsidiary	Any other transaction	Other Receivables (Expense Recovery Balances)	0.00	Not Applicable			0.00	197.00	204.00
90	Wockhardt Limited	Wockhardt Bioscience Limited	Wholly Owned Subsidiary	Any other transaction	Other Receivables (Expense Recovery Balances)	0.00	Not Applicable			0.00	3.00	3.00
91	Wockhardt Limited	Wockhardt Medicines Limited	Wholly Owned Subsidiary	Any other transaction	Other Receivables (Expense Recovery Balances)	0.00	Not Applicable			0.00	6.00	6.00
92	Wockhardt Limited	Pinewood Laboratories Limited	Step down subsidiary	Any other transaction	Other Receivables (Expense Recovery Balances)	0.00	Not Applicable			0.00	122.00	126.00
93	Wockhardt Limited	CP Pharmaceuticals Limited	Step down subsidiary	Any other transaction	Advance paid (Balances)	0.00	Not Applicable			0.00	44.00	0.00
94	Wockhardt Limited	Wockhardt Hospitals Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Trade Receivables (Balances)	0.00	Not Applicable			0.00	26.00	27.00
95	Wockhardt Limited	Wockhardt Regenerative Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Trade Receivables (Balances)	0.00	Not Applicable			0.00	97.00	97.00
96	Wockhardt Limited	Wockhardt Regenerative Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Trade Payables (Balances)	0.00	Not Applicable			0.00	335.00	61.00
97	Wockhardt Limited	Carol Info Services Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Trade Payables (Balances)	0.00	Not Applicable			0.00	268.00	238.00
98	Wockhardt Limited	Palanpur Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Trade Payables (Balances)	0.00	Not Applicable			0.00	712.00	753.00
99	Wockhardt Limited	Merind Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Trade Payables (Balances)	0.00	Not Applicable			0.00	1.00	1.00
100	Wockhardt Limited	Khorakiwala Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Balances (Loan)	0.00	Not Applicable			0.00	30,950.00	19,423.00
101	Wockhardt Limited	Merind Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Balances (Loan)	0.00	Not Applicable			0.00	13,411.00	13,411.00
102	Wockhardt Limited	Themisto Trustee Company Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Balances (Loan)	0.00	Not Applicable			0.00	1,946.00	0.00
103	Wockhardt Limited	Callirhoe Trustee Company Pvt Ltd	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Balances (Loan)	0.00	Not Applicable			0.00	11,627.00	7,215.00
104	Wockhardt Limited	Carol Info Services Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Security Deposit Given (Balances)	0.00	Not Applicable			0.00	5,550.00	5,550.00
105	Wockhardt Limited	Palanpur Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Security Deposit Given (Balances)	0.00	Not Applicable			0.00	275.00	275.00
106	Wockhardt Limited	Wockhardt Regenarative Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	2.00	2.00
107	Wockhardt Limited	Carol Info Services Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	114.00	135.00
108	Wockhardt Limited	Khorakiwala Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	231.00	245.00
109	Wockhardt Limited	Palanpur Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	97.00	104.00
110	Wockhardt Limited	Denarius Estate Development Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
111	Wockhardt Limited	Dr. Habil Khorakiwala Education and Health Foundation (Section 8)	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
112	Wockhardt Limited	Adrastea Trading and Services LLP	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
113	Wockhardt Limited	Lysithea Consultants	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
114	Wockhardt Limited	Lysithea Discretionary Trust	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
115	Wockhardt Limited	Themisto Trustee Company Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
116	Wockhardt Limited	Banneret Trading Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
117	Wockhardt Limited	HZ Trading and Services LLP	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
118	Wockhardt Limited	HNZ Discretionary Trust	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
119	Wockhardt Limited	Dartmour Holdings Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
120	Wockhardt Limited	Amadou Estate Development Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
121	Wockhardt Limited	Callirhoe Trustee Company Privated Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
122	Wockhardt Limited	Shravan Constructions Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
123	Wockhardt Limited	Holmdene Constructions	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	17.00	18.00
124	Wockhardt Limited	Sharanya Chemicals And Pharmaceuticals Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
125	Wockhardt Limited	HNZ Trading and Services LLP	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
126	Wockhardt Limited	HNZ Consultants	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
127	Wockhardt Limited	Khorakiwala Foundation	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
128	Wockhardt Limited	Ananke Trustee Company Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
129	Wockhardt Limited	Pasithee Trustee Company Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
130	Wockhardt Limited	Megaclite Trading Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
131	Wockhardt Limited	Genista Trading and Services Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
132	Wockhardt Limited	Impala Advisory Services Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
133	Wockhardt Limited	Sinope Advisory Services Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
134	Wockhardt Limited	Step Forward Advisory Services Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
135	Wockhardt Limited	Kendo Advisory Services Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
136	Wockhardt Limited	Lysithea Trading and Services LLP	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
137	Wockhardt Limited	Helike Trading and Services LLP	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
138	Wockhardt Limited	Amalthea Consultants	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
139	Wockhardt Limited	Amalthea Trading and Services LLP	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
140	Wockhardt Limited	Amalthea Discretionary Trust	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
141	Wockhardt Limited	Dr. Habil Khorakiwala Education and Health Foundation ( Trust) [Wockhardt Global School]	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	548.00	1,015.00
142	Wockhardt Limited	Wockhardt Foundation	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	1.00	1.00
143	Wockhardt Limited	Merind Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	97.00	104.00
144	Wockhardt Limited	Wockhardt Hospitals Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Other Receivables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
145	Wockhardt Limited	Humuza Consultants	Promoter Entity	Any other transaction	Other Payables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
146	Wockhardt Limited	Habil Khorakiwala Trust	Promoter Group Entity	Any other transaction	Other Payables (Balances)	0.00	Not Applicable			0.00	10.00	10.00
147	Wockhardt Infrastructure Development Limited	Wockhardt Medicines Limited	Fellow Subsidiary	Any other transaction	Interet Expense	0.00	Not Applicable			1.00	2.00	3.00				Textual Information(5)
148	Wockhardt Infrastructure Development Limited	Wockhardt Medicines Limited	Fellow Subsidiary	Any other transaction	Balances (Loan)	0.00	Not Applicable			0.00	16.00	16.00
149	Wockhardt Infrastructure Development Limited	Wockhardt Foundation	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	CSR Spend	0.00	Not Applicable			31.00	0.00	0.00
150	Wockhardt Bio AG	Wockahardt Bio Pty Ltd, Australia	Subsidiary	Any other transaction	Debtors (Balances)	0.00	Not Applicable			0.00	69.00	139.00
151	Wockhardt Bio AG	Wockahardt Bio Pty Ltd, Australia	Subsidiary	Any other transaction	Advance recceived for supplies (Balances)	0.00	Not Applicable			0.00	319.00	350.00
152	Wockhardt Bio AG	Wockahardt Bio Pty Ltd, Australia	Subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	58.00	64.00
153	Wockhardt Bio AG	Wockahardt Bio Pty Ltd, Australia	Subsidiary	Sale of goods or services		26,000.00	Approved			83.00	0.00	0.00
154	Wockhardt Bio AG	Z & Z Services GmbH, Germany	Subsidiary	Any other transaction	Loan (Balances)	0.00	Not Applicable			0.00	134.00	145.00
155	Wockhardt Bio AG	Wockhardt Europe Limited	Fellow Subsidiary	Any other transaction	Loan (Balances)	0.00	Not Applicable			0.00	1,479.00	1,145.00
156	Wockhardt Bio AG	CP Pharmaceuticals Limited	Subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	46,003.00	49,012.00
157	Wockhardt Bio AG	CP Pharmaceuticals Limited	Subsidiary	Purchase of goods or services		4,43,926.00	Approved			18,810.00	0.00	0.00
158	Wockhardt Bio AG	CP Pharmaceuticals Limited	Subsidiary	Any other transaction	Expense reimbursed	0.00	Not Applicable			2,950.00	0.00	0.00
159	Wockhardt Bio AG	Wockhardt Farmaceutica SA DE CV	Subsidiary	Any other transaction	Debtors (Balances)	0.00	Not Applicable			0.00	10,932.00	11,578.00
160	Wockhardt Bio AG	Wockhardt Farmaceutica SA DE CV	Subsidiary	Any other transaction	Loan (Balances)	0.00	Not Applicable			0.00	2,584.00	2,737.00
161	Wockhardt Bio AG	Wockahrdt UK Limited	Subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	1,277.00	39.00
162	Wockhardt Bio AG	Wockahrdt UK Limited	Subsidiary	Any other transaction	Debtors (Balances)	0.00	Not Applicable			0.00	8,749.00	8,266.00
163	Wockhardt Bio AG	Wockahrdt UK Limited	Subsidiary	Sale of goods or services		4,43,926.00	Approved			20,764.00	0.00	0.00
164	Wockhardt Bio AG	Wockhardt Bio (R) LLC	Subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	1.00	1.00
165	Wockhardt Bio AG	Pinewood Laboratories Limited	Step down subsidiary	Any other transaction	Loan (Balances)	0.00	Not Applicable			0.00	3,912.00	4,042.00
166	Wockhardt Bio AG	Pinewood Laboratories Limited	Step down subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	2,988.00	2,334.00
167	Wockhardt Bio AG	Pinewood Laboratories Limited	Step down subsidiary	Sale of goods or services		4,43,926.00	Approved			770.00	0.00	0.00
168	Wockhardt Bio AG	Pinewood Laboratories Limited	Step down subsidiary	Any other transaction	Interest Expense	0.00	Not Applicable			194.00	0.00	0.00
169	Wockhardt Bio AG	Morton Grove Pharmaceuticals Inc. (consolidated)	Step down subsidiary	Any other transaction	Expense reimbursed	0.00	Not Applicable			59.00	0.00	0.00
170	CP Pharmaceuticals Limited	Wockhardt UK Holdings Limited	Fellow Subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	8,730.00	9,083.00
171	CP Pharmaceuticals Limited	Wockhardt UK Holdings Limited (consolidated)	Fellow Subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	3,242.00	3,373.00
172	CP Pharmaceuticals Limited	Pinewood Laboratories Limited	Fellow Subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	1,531.00	1,282.00
173	CP Pharmaceuticals Limited	Pinewood Laboratories Limited	Fellow Subsidiary	Purchase of goods or services		7,000.00	Appoved			3,418.00	0.00	0.00
174	CP Pharmaceuticals Limited	Pinewood Laboratories Limited	Fellow Subsidiary	Any other transaction	Advance given (Balances)	0.00	Not Applicable			0.00	338.00	3.00
175	CP Pharmaceuticals Limited	Wockahrdt UK Limited	Fellow Subsidiary	Any other transaction	Debtors (Balances)	0.00	Not Applicable			0.00	48.00	64.00
176	CP Pharmaceuticals Limited	Wockahrdt UK Limited	Fellow Subsidiary	Any other transaction	Expense recovered	0.00	Not Applicable			250.00	0.00	0.00
177	Wockhardt UK Holdings Limited (Consolidated)	Wockhardt Farmaceutica Do Brasil Ltda	Subsidiary	Any other transaction	Loan (Balances)	0.00	Not Applicable			0.00	165.00	172.00
178	Wockhardt UK Limited	Pinewood Healthcare Limited	Fellow Subsidiary	Any other transaction	Debtors (Balances)	0.00	Not Applicable			0.00	39.00	0.00
179	Wockhardt UK Limited	Pinewood Laboratories Limited	Fellow Subsidiary	Any other transaction	Debtors (Balances)	0.00	Not Applicable			0.00	64.00	64.00
180	Wockpharma Ireland Limited	Pinewood Laboratories Limited	Subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	16,257.00	16,794.00
181	Wockhardt Farmaceutica SA DE CV	Wockhardt Services SA DE CV	Fellow Subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	909.00	963.00
182	Wockhardt Service SA DE CV	Wockhardt Bio AG	Parent Company	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	418.00	442.00
183	Wockhardt UK Holdings Limited (consolidated)	CP Pharmaceuticals Limited	Fellow subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	72.00	75.00
184	Wockhardt Bio AG	Wockhardt Antibiotics Ireland	Subsidiary	Any other transaction	Loan (Balances)	0.00	Not Applicable			0.00	0.00	22.00
185	Wockhardt Bio AG	Wockhardt Antibiotics Ireland	Subsidiary	Any other transaction	Creditors (Balances)	0.00	Not Applicable			0.00	0.00	955.00
186	Wockhardt Bio AG	Wockhardt Suisse AG	Subsidiary	Any other transaction	Debtors (Balances)	0.00	Not Applicable			0.00	0.00	114.00
187	Wockhardt Bio AG	Wockhardt Suisse AG	Subsidiary	Loan		0.00	Not Applicable			268.00	0.00	268.00
188	Wockhardt Bio AG	Wockhardt Suisse USA LLC	Subsidiary	Loan		0.00	Not Applicable			461.00	0.00	461.00
189	Wockhardt Suisse AG	Wockhardt Suisse USA holding Corporation	Subsidiary	Loan		300.00	Approved			268.00	0.00	268.00
190	Wockhardt Suisse USA holding Corporation	Wockhardt Suisse USA LLC	Subsidiary	Loan		300.00	Approved			268.00	0.00	268.00
191	Wockhardt Bio AG	Pinewood Healthcare Limited	Subsidiary	Any other transaction	Debtors (Balances)	0.00	Not Applicable			0.00	0.00	1,747.00
192	Wockhardt Bio AG	Pinewood Healthcare Limited	Subsidiary	Sale of goods or services		5,000.00	Approved			2,431.00	0.00	0.00
193	Wockhardt Limited	Wockhardt UK Limited	Step down subsidiary	Any other transaction	Reimbursement received	0.00	Not Applicable			11.00	0.00	0.00
194	Wockhardt Limited	Pinewood Laboratories Ltd	Step down subsidiary	Any other transaction	Reimbursement received	0.00	Not Applicable			4.00	0.00	0.00
195	Wockhardt Limited	CP Pharmaceuticals Limited	Step down subsidiary	Any other transaction	Reimbursement paid	0.00	Not Applicable			31.00	0.00	0.00
196	Wockhardt Limited	Khorakiwala Holdings and Investments Private Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Recovery of Support Service Cost	20.00	Approved			6.00	0.00	0.00
197	Wockhardt Limited	Miqdad H Khorakiwala	Relatives of Key Managerial Personnel	Any other transaction	Employee Cost paid	4.00	Approved			3.00	0.00	0.00
198	Wockhardt Limited	Merind Limited	Enterprises over which Key Managerial Personnel exercise significant influence/control	Any other transaction	Trade Receivables (Balances)	0.00	Not Applicable			0.00	0.00	2.00
199	Wockhardt Bio AG	Pinewood Laboratories Limited	Step down subsidiary	Any other transaction	Debtors (Balances)	0.00	Not Applicable			0.00	125.00	0.00
200	CP Pharmaceuticals Limited	Pinewood Healthcare Limited	Fellow subsidiary	Any other transaction	Debtors (Balances)	0.00	Not Applicable			0.00	10.00	0.00
201	CP Pharmaceuticals Limited	Pinewood Laboratories Limited	Fellow Subsidiary	Any other transaction	Debtors (Balances)	0.00	Not Applicable			0.00	6.00	0.00
202	CP Pharmaceuticals Limited	Wockahrdt UK Limited	Fellow Subsidiary	Any other transaction	Payables (Balances)	0.00	Not Applicable			0.00	652.00	0.00
203	Wockhardt Bio AG	Morton Grove Pharmaceuticals Inc. (consolidated)	Step down subsidiary	Any other transaction	Debtors (Balances)	0.00	Not Applicable			0.00	48.00	60.00
Total value of transaction during the reporting period										1,43,772.00

Sr.	Original Object	Modified Object, if any	Original Allocation	Modified allocation, if any	Funds Utilised	Amount of Deviation/Variation for the quarter according to applicable object	Remarks if any
1	Repayment and/or pre-payment, in full or part, of certain borrowings availed by our Company.	NO	50,000.00	0.00	50,000.00	0.00
2	Funding in capital expenditure, investment in research and development and incidental expenses.	NO	25,000.00	0.00	8,767.00	0.00	In view of business exigencies and ongoing project timelines, the period for utilisation of the issue proceeds has been reviewed and extended by the Board upto financial year 2028 vide its resolution dated 4th May 2026.
3	General Corporate Purpose	NO	22,397.00	22,779.00	22,779.00	0.00

Name of signatory	Rashmi Mamtura
Designation of person	Company Secretary and Compliance Officer
Place	Mumbai
Date	04-05-2026

Integrated Filing — IndAS

General information about company

Financial Results Ind-AS

Amount in (Lakhs)

Disclosure of notes on financial results

Remarks

Statement of Asset and Liabilities

Amount in (Lakhs)

Text Block

Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Other Comprehensive Income

Amount in (Lakhs)

Cash flow statement, indirect

Amount in (Lakhs)

Details of Impact of Audit Qualification

Amount in (Lakhs)

Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Signatory Details

Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Text Block

Textual Information(1)	1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate. Please note exchange rate as considered below: a. For Opening balance Exchange Rate is considered as on October 01, 2025. b. For Closing balance Exchange Rate is considered as on March 31, 2026. c. For the value of transactions during the period, Average Exchange Rate is considered. 2. The value of the related party transaction approved by the audit committee is shown as '0' which does not required approval of Audit Committee as per SEBI LODR Regulations, 2015.
Textual Information(2)	The actual value of transaction is 0.004 Crore
Textual Information(3)	The actual value of transaction is 0.004 Crore
Textual Information(4)	The actual value of transaction is 0.001 Crore
Textual Information(5)	The Opening Balance is Rs. 0.025 Crore, The Actual value of transaction is Rs. 0.005 Crore and the Closing Balance is 0.03 Crore.